Publications

Medicine Quality Publications

Global access to quality-assured medical products: the Oxford Statement and call to action

The Lancet Global Health

Published: 7 Nov 2019

Author(s): Paul N Newton, Katherine C Bond, on behalf of the Oxford Statement signatories

DOI: https://doi.org/10.1016/S2214-109X(19)30426-7  

Quality of medical products for diabetes management: a systematic review

BMJ Global Health

Published: 24 Sep 2019

Author(s): Kartika Saraswati, Chanvilay Sichanh, Paul N Newton, Céline Caillet

DOI: http://dx.doi.org/10.1136/bmjgh-2019-001636

Field detection devices for screening the quality of medicines: a systematic review

Published: 29 Aug 2018

Author(s): Vickers S, Bernier M, Zambrzycki S, et al.

DOI: http://dx.doi.org/10.1136/bmjgh-2018-000725

An evaluation of portable screening devices to assess medicines quality for national Medicines Regulatory Authorities - Supplementary Annex Book

Published: 19 Jun 2018

Author(s): Asia Development Bank (ADB), Infectious Diseases Data Observatory, Mahidol-Oxford Research Unit, Georgia Tech

An evaluation of portable screening devices to assess medicines quality for national Medicines Regulatory Authorities

Published: 19 Jun 2018

Author(s): Asia Development Bank (ADB), Infectious Diseases Data Observatory, Mahidol-Oxford Research Unit, Georgia Tech

Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome

American Journal of Respiratory and Critical Care Medicine

Published: 15 Mar 2018

Author(s): Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, Jose J, Pinto R, Al-Omari A, Kharaba A, Almotairi A, Al Khatib K, Alraddadi B, Shalhoub S, Abdulmomen A, Qushmaq I, Mady A, Solaiman O, Al-Aithan AM, Al-Raddadi R, Ragab A, Balkhy HH1, Al Harthy A, Deeb AM, Al Mutairi H, Al-Dawood A1, Merson L, Hayden FG, Fowler RA, Saudi Critical Care Trial Group

DOI: https://doi.org/10.1164/rccm.201706-1172OC

PMID: 29161116

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries

Malaria Journal, 16:204

Published: 25 May 2017

Author(s): Newton, P.N., Hanson, K. and Goodman, C

DOI: https://doi.org/10.1186/s12936-017-1818-8

PMID: 28539125

Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People's Democratic Republic

Drug Safety, 40:9

Published: 20 May 2017

Author(s): Caillet C, Sichanh C, Assemat G, Malet-Martino M, Sommet A, Bagheri H, Sengxeu N, Mongkhonmath N, Mayxay M, Syhakhang L, Lapeyre-Mestre M, Newton PN, Roussin A

DOI: 10.1007/s40264-017-0544-z

PMID: 28528487

Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint

Trop Med Int Health

Published: 21 Dec 2016

Author(s): Ravinetto, R. et al.

DOI: https://doi.org/10.1111/tmi.12784

Fake penicillin, The Third Man, and Operation Claptrap

BMJ

Published: 13 Dec 2016

Author(s): Newton, P.N. and Timmermann, B.

DOI: https://doi.org/10.1136/bmj.i6494